SIREN : 433162039
PHARMA 6 is a French company founded 25 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MULHOUSE (68200), this company of category PME shows in 2021 a revenue of 3.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | 3 201 697 € | 3 225 201 € | 3 100 939 € | 3 031 396 € | 3 000 998 € | 3 003 583 € |
| Net income | 33 349 € | 19 764 € | -94 902 € | 45 371 € | 42 725 € | 28 964 € | -67 549 € | 25 059 € |
| EBITDA | N/C | N/C | 61 825 € | 111 578 € | 107 232 € | 84 528 € | 33 589 € | 42 707 € |
| Net margin | N/C | N/C | -3.0% | 1.4% | 1.4% | 1.0% | -2.3% | 0.8% |
In 2023, PHARMA 6 generates positive net income of 33 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 25 k€ -> 33 k€.
33 349 €
The debt ratio (= Financial debt / Equity x 100) stands at 200%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. The balance between equity and debt is satisfactory.
199.878%
20.361%
28.9%
In 2023, the debt ratio of PHARMA 6 (199.88) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of PHARMA 6 (20.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2021, the repayment capacity of PHARMA 6 (-4.59) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 194.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
194.715
In 2023, the liquidity ratio of PHARMA 6 (194.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2021, the interest coverage of PHARMA 6 (9.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 220 transactions of similar company sales in 2023, the value of PHARMA 6 is estimated at 393 500 € (range 239 306€ - 553 173€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHARMA 6 with other companies in the same sector:
The revenue of PHARMA 6 in 2021 is 3.2 M€.
Yes, PHARMA 6 generated a net profit of 33 k€ in 2023.
The headquarters of PHARMA 6 is located in MULHOUSE (68200), in the department Haut-Rhin.
The tax return of PHARMA 6 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMA 6 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.